Related Experiment Video
Updated: Feb 15, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic
C De la Calle1, H G Ternavasio-de la Vega2, L Morata1
1Department of Infectious Diseases, Hospital Clínic, Barcelona, Spain.
Objective:
Combining a macrolide or a fluoroquinolone to beta-lactam regimens in the treatment of patients with moderate to severe community-acquired pneumonia is recommended by the international guidelines. However, the information in patients with bacteraemic pneumococcal pneumonia is limited.
Methods:
A propensity score technique was used to analyze prospectively collected data from all patients with bacteraemic pneumococcal pneumonia admitted from 2000 to 2015 in our institution, who had received empirical treatment with third-generation cephalosporin in monotherapy or plus macrolide or fluoroquinolone.
Results:
We included 69 patients in the monotherapy group and 314 in the combination group. After adjustment by PS for receiving monotherapy, 30-day mortality (OR 2.89; 95% CI 1.07-7.84) was significantly higher in monotherapy group. A higher 30-day mortality was observed in monotherapy group in both 1:1 and 1:2 matched samples although it was statistically significant only in 1:2 sample (OR: 3.50 (95% CI 1.03-11.96), P = 0.046).
Conclusions:
Our study suggests that in bacteraemic pneumococcal pneumonia, empirical therapy with a third-generation cephalosporin plus a macrolide or a fluoroquinolone is associated with a lower mortality rate than beta-lactams in monotherapy. These results support the recommendation of combination therapy in patients requiring admission with moderate to severe disease.
Insights
Combination antibiotic therapy for bacteraemic pneumococcal pneumonia, using a macrolide or fluoroquinolone with a cephalosporin, significantly reduces 30-day mortality compared to monotherapy. This supports current treatment guidelines for severe pneumonia.
Area of Science:
- Infectious Diseases
- Bacteriology
- Pharmacology
Background:
- International guidelines recommend combining macrolides or fluoroquinolones with beta-lactams for moderate to severe community-acquired pneumonia.
- Limited data exists on combination therapy specifically for bacteraemic pneumococcal pneumonia.
Purpose of the Study:
- To evaluate the impact of empirical antibiotic therapy on mortality in patients with bacteraemic pneumococcal pneumonia.
- To compare the outcomes of monotherapy versus combination therapy (cephalosporin plus macrolide or fluoroquinolone).
Main Methods:
- Propensity score analysis of prospectively collected data from 2000-2015.
- Inclusion of patients with bacteraemic pneumococcal pneumonia treated with third-generation cephalosporin monotherapy or combination therapy.
- Comparison of 30-day mortality between monotherapy (n=69) and combination (n=314) groups after propensity score adjustment.
Main Results:
- Monotherapy was associated with significantly higher 30-day mortality (OR 2.89) after propensity score adjustment.
- Higher mortality in the monotherapy group was observed in both 1:1 and 1:2 matched samples, statistically significant in the 1:2 sample (OR 3.50).
Conclusions:
- Empirical combination therapy (third-generation cephalosporin plus macrolide or fluoroquinolone) is associated with lower mortality in bacteraemic pneumococcal pneumonia compared to monotherapy.
- These findings support the use of combination therapy for hospitalized patients with moderate to severe disease.
More Related Videos
09:20Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Introduction to z Scores
z scores...
Introduction to z Scores
z scores...
z Scores and Area Under the Curve